Complex Mechanisms in Prostatic Inflammatory Response

Slides:



Advertisements
Similar presentations
Medical Management for BPH: The Role of Combination Therapy
Advertisements

Pascal Rischmann  European Urology Supplements 
Prostate Cancer 2008: Challenges in Diagnosis and Management
Volume 57, Issue 3, Pages e22-e23 (March 2010)
Management of Acute and Chronic Retention in Men
Volume 60, Issue 1, Pages (July 2011)
Robotic Cystectomy Versus Open Cystectomy: Are We There Yet?
Bladder Cancer: Management and Future Directions
Martin C. Michel  European Urology Supplements 
Treatment of Advanced and Metastatic Renal Cancer: A Revolution?
Cholinergic Innervation and Muscarinic Receptors in the Human Prostate
Bladder Cancer: A Major Public Health Issue
Back to the Future: Introduction and Conclusions
Alexandre de la Taille  European Urology Supplements 
Pseudohyperplastic Adenocarcinoma of the Prostate
Volume 51, Issue 1, Pages (January 2007)
Long-Term Management of Overactive Bladder with Antimuscarinic Agents
Diagnostic Strategies for Prostate Cancer
Is Benign Prostatic Hyperplasia (BPH) an Immune Inflammatory Disease?
Treatment of Symptomatic Benign Prostatic Hyperplasia: Current and Future Clinical Practice in Europe – What is Really Happening?  Bob Djavan  European.
Inflammation and Chronic Prostatic Diseases: Evidence for a Link?
Counselling the Prostate Cancer Patient
Luis Martínez-Piñeiro  European Urology Supplements 
Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?  Michel Bolla  European.
An Update of Current Practice in Hypospadias Surgery
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Richard C. Harkaway  European Urology Supplements 
Tim Schneider  European Urology Supplements 
Fouad K. Habib  European Urology Supplements 
Philip Toozs-Hobson, Pallavi Latthe  European Urology Supplements 
The Importance of Testosterone Control in Prostate Cancer
Jacques Irani  European Urology Supplements 
Optimal Testosterone Control and Eligard®
Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice  Claus Roehrborn  European Urology.
Neal Shore  European Urology Supplements 
The Hallmarks of BPH Progression and Risk Factors
Sergio Bracarda  European Urology Supplements 
Challenges and Opportunities in Hormone-Resistant Prostate Cancer
Bisphosphonates Can Prevent Skeletal Complications of Malignant Bone Disease from Prostate Cancer and Renal Cell Carcinoma  Fred Saad  European Urology.
New Trends in Managing the Prostate Cancer Patient
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Prostate Cancer 2008: Challenges in Diagnosis and Management
Martin Michel, Jean de la Rosette  European Urology Supplements 
How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?  Vincenzo Mirone 
Richard Berges  European Urology Supplements 
Axel Heidenreich  European Urology Supplements 
Improving Flexibility and Quality of Life for Your Patients: A Must?
Bob Djavan  European Urology Supplements 
Androgen Receptor Mediated Growth of Prostate (Cancer)
Epidemiology, Pathogenesis, and Pathophysiology of Urolithiasis
The Benefits of Dual Inhibition of 5α Reductase
Prognostic Factors in Non–Muscle-Invasive Bladder Tumors
Testim® Gel: Review of Clinical Data
C.G Roehrborn, T McNicholas  European Urology Supplements 
Beyond Skeletal-Related Events
Treatment Options in Prostate Cancer Once Primary Therapy Fails
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Joaquim Bellmunt  European Urology Supplements 
Classification of Mixed Incontinence
The Impact of Premature Ejaculation on Partners and Relationships
Emmanuel Chartier-Kastler, Andrea Tubaro  European Urology Supplements 
Epidemiology and Demographics of Prostatitis
New Research Findings on Clinical Benefits of Bisphosphonates in Patients With Advanced Prostate Cancer  Noel W. Clarke  European Urology Supplements 
Fouad K. Habib  European Urology Supplements 
Jan Roigas  European Urology Supplements 
Axel Heidenreich  European Urology Supplements 
Michael Marberger  European Urology Supplements 
Introduction European Urology Supplements
Presentation transcript:

Complex Mechanisms in Prostatic Inflammatory Response Bob Djavan, Elisabeth Eckersberger, Geovanni Espinosa, Gero Kramer, Alessandra Handisurya, Chung Lee, Michael Marberger, Herbert Lepor, Georg E. Steiner  European Urology Supplements  Volume 8, Issue 13, Pages 872-878 (December 2009) DOI: 10.1016/j.eursup.2009.11.003 Copyright © 2009 Terms and Conditions

Fig. 1 Proliferative inflammatory atrophy; immunohistochemistry using anti-CD3. Reproduced with permission of MedReviews®, LLC. Steiner GE, Djavan B, Kramer G, et al. The picture of the prostatic lymphokine network is becoming increasingly complex. Rev Urol 2002;4:171–7. Reviews in Urology is a copyrighted publication of MedReviews®, LLC. All rights reserved [8]. European Urology Supplements 2009 8, 872-878DOI: (10.1016/j.eursup.2009.11.003) Copyright © 2009 Terms and Conditions

Fig. 2 “Scattered” type of inflammation; immunohistochemistry using anti-CD3. Reproduced with permission of MedReviews®, LLC. Steiner GE, Djavan B, Kramer G, et al. The picture of the prostatic lymphokine network is becoming increasingly complex. Rev Urol 2002;4:171–7. Reviews in Urology is a copyrighted publication of MedReviews®, LLC. All rights reserved [8]. European Urology Supplements 2009 8, 872-878DOI: (10.1016/j.eursup.2009.11.003) Copyright © 2009 Terms and Conditions

Fig. 3 Kinetics of epithelial cell killing by prostatic T lymphocytes. Parallel time-lapse microscopy of autologous epithelial cell killing by prostatic T lymphocytes derived from a prostatic specimen with benign prostatic hyperplasia. Reproduced with permission of MedReviews®, LLC. Steiner GE, Djavan B, Kramer G, et al. The picture of the prostatic lymphokine network is becoming increasingly complex. Rev Urol 2002;4:171–7. Reviews in Urology is a copyrighted publication of MedReviews®, LLC. All rights reserved [8]. European Urology Supplements 2009 8, 872-878DOI: (10.1016/j.eursup.2009.11.003) Copyright © 2009 Terms and Conditions